“Background: Sacrococcygeal teratoma (SCT) is the commones


“Background: Sacrococcygeal teratoma (SCT) is the commonest neonatal neoplasm. Its long-term effects are important in prenatal counseling and the delivery of an appropriate postoperative plan.\n\nAim: To determine the long-term functional outcome after SCT excision in a UK regional center.\n\nStudy Design: Follow-up data for all patients with a SCT excised at the John Radcliffe Hospital in Oxford was collected retrospectively from notes and prospectively in clinic visits.\n\nOutcome Measures: Clinical evidence of bowel or bladder impairment. Go 6983 TGF-beta/Smad inhibitor mortality.\n\nResults: Over a 14-year

period. 18 patients had a histologic diagnosis of SCT. Nine patients (50%,) were born. 7 (39%) were terminated. and 2 (11%) were stillbirths. Of the 9 patients who had SCT resection. 4 (44%) were antenatally diagnosed. There were no perioperative deaths and alpha-fetoprotein levels normalized by 6 to 12 months after tumor resection. Median follow-up of patients, was 30 months mTOR cancer (range: 6 to 132 mo) with 1 patient lost to follow-up at 6 months. although he was asymptomatic at file time. Three patients developed urologic complications (2 within 1 year of tumor resection). including 2 patients with neurogenic bladder dysfunction and 1 patient with detrusor sphincter dyssynergia.\n\nConclusions:

Approximately one-third of patients will develop major urologic complications after resection of SCT. Routine ultrasonography in the first postoperative year Givinostat after tumor resection may help to identify patients with neuropathic bladder at the early stage and predict late complications. Parents need to be aware of this potential long-term complication during prenatal counseling and the need for regular long-term follow-Lip with the pediatric surgical team.”
“Gamma-glutamyl transferase (GGT) is a marker for cardiovascular risk and an independent predictor of long-term outcome in adults. Epidemiological data from pediatric cohorts are rare. We studied the association of GGT to body mass index as a standard deviation score, sex, and age in 68,415 children (age 11.7 +/- 4.4 years; 48% boys; body mass index

27.2 +/- 7.4 kg/m(2); GGT measured in n = 23,955). GGT > 50 U/L is strongly associated with extreme obesity (odds ratio 27.13, 95% confidence interval 15.07-48.85) and male sex (odds ratio 2.60, 95% confidence interval 2.03-3.31). GGT seems to be of clinical relevance and may be marketable as a surrogate in risk profiling for children with obesity.”
“Background and aim of the study: Rheumatic heart disease is the most common cause of multivalvular disease in developing countries. Unless aggressive and timely intervention in the form of valve replacement is pursued, the condition progresses rapidly to disability and death. Combined mitral-aortic valve replacement represents a major technical challenge, and carries high early and late mortality rates.

Comments are closed.